ConductScience.org, home
A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
API referenceFor AI assistants

Trial · NCT04281472

Adverse events78

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 78

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherINJECTION SITE ERYTHEMAGeneral disordersStage A: Efgartigimod PH20 SC33322
otherINJECTION SITE ERYTHEMAGeneral disordersStage B: Efgartigimod PH20 SC6111
otherINJECTION SITE ERYTHEMAGeneral disordersStage B: Placebo PH20 SC0110
otherHEADACHENervous system disordersStage A: Efgartigimod PH20 SC16322
otherHEADACHENervous system disordersStage B: Efgartigimod PH20 SC4111
otherHEADACHENervous system disordersStage B: Placebo PH20 SC2110
otherINJECTION SITE BRUISINGGeneral disordersStage A: Efgartigimod PH20 SC4322
otherINJECTION SITE BRUISINGGeneral disordersStage B: Efgartigimod PH20 SC6111
otherINJECTION SITE BRUISINGGeneral disordersStage B: Placebo PH20 SC1110
otherCOVID-19Infections and infestationsStage A: Efgartigimod PH20 SC6322
otherCOVID-19Infections and infestationsStage B: Efgartigimod PH20 SC19111
otherCOVID-19Infections and infestationsStage B: Placebo PH20 SC14110
otherUPPER RESPIRATORY TRACT INFECTIONInfections and infestationsStage A: Efgartigimod PH20 SC11322
otherUPPER RESPIRATORY TRACT INFECTIONInfections and infestationsStage B: Efgartigimod PH20 SC2111
otherUPPER RESPIRATORY TRACT INFECTIONInfections and infestationsStage B: Placebo PH20 SC11110
seriousCARDIAC ARRESTCardiac disordersStage A: Efgartigimod PH20 SC1322
seriousCARDIAC ARRESTCardiac disordersStage B: Efgartigimod PH20 SC0111
seriousCARDIAC ARRESTCardiac disordersStage B: Placebo PH20 SC0110
seriousCLOSTRIDIUM DIFFICILE COLITISInfections and infestationsStage A: Efgartigimod PH20 SC1322
seriousCLOSTRIDIUM DIFFICILE COLITISInfections and infestationsStage B: Efgartigimod PH20 SC0111

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04281472/events

API referenceFor AI assistants